Report cover image

Clinical Trials Outsourcing Market Size, Share, and Analysis, By Phase (Phase I, Phase II, Phase III, Phase IV), By Application (Cancer, Cardiovascular Diseases, Nervous System Diseases, Infectious Diseases, Musculoskeletal Disease, Gastroenterology Disea

Publisher Fatpos Global
Published Jan 01, 2025
Length 492 Pages
SKU # FAGL19607326

Description

Clinical Trials Outsourcing Market Size, Share, and Analysis, By Phase (Phase I, Phase II, Phase III, Phase IV), By Application (Cancer, Cardiovascular Diseases, Nervous System Diseases, Infectious Diseases, Musculoskeletal Disease, Gastroenterology Diseases, and Others), By Services Type (Protocol Designing, Site Identification, Patient Recruitment, Laboratory Services, Bioanalytical Testing Services, Clinical Trial Data Management Services, and Others), By End-User (Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, and Others), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034

PRODUCT OVERVIEW

Clinical Trials Outsourcing Market is projected to exhibit a Compound Annual Growth Rate (CAGR) of 7.1% during the forecast span from 2024 to 2034. In 2023, the market size was assessed at USD 44.4 billion and is projected to reach USD 94.3 billion by the completion of 2034.

Clinical trials outsourcing involves delegating various aspects of clinical research to external organizations, typically Contract Research Organizations (CROs). This strategy is utilized by pharmaceutical, biotechnology, and medical device companies to leverage specialized expertise, enhance efficiency, and reduce costs. The tasks outsourced can include study design, patient recruitment, data collection and processing, regulatory compliance, and statistical analysis. By partnering with CROs, sponsors benefit from access to cutting-edge technologies, global patient populations, and expert knowledge without the need for extensive in-house resources. This approach also offers greater flexibility and scalability in conducting clinical trials, ultimately accelerating the development and approval of new therapies and medical products.

MARKET HIGHLIGHTS

Clinical Trials Outsourcing Market is expected to reach USD 94.3 billion during the forecast period, due to the increasing complexity and cost of clinical research. Key factors contributing to this growth include rising R&D expenditures, an expanding drug development pipeline, and the globalization of clinical trials. Outsourcing to CROs helps companies manage these complexities efficiently. However, the market faces several challenges, such as regulatory compliance across different countries, data security and patient confidentiality, maintaining high-quality standards, managing communication across multiple stakeholders, and navigating the competitive landscape. Despite these hurdles, the demand for outsourcing is expected to grow as companies seek cost-effective and efficient ways to bring new treatments to market.

Clinical Trials Outsourcing Market Segments:
  • By Phase
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • By Application
  • Cancer
  • Cardiovascular Diseases
  • Nervous System Diseases
  • Infectious Diseases
  • Musculoskeletal Disease
  • Gastroenterology Diseases
  • Others
  • By Services Type
  • Protocol Designing
  • Site Identification
  • Patient Recruitment
  • Laboratory Services
  • Bioanalytical Testing Services
  • Clinical Trial Data Management Services
  • Others
  • By End-User
  • Pharmaceutical & Biopharmaceutical Companies
  • Medical Device Companies
  • Others
MARKET DYNAMICS

Growth Drivers

Increasing R&D expenditure and drug development pipelines is Expected to Foster Market Expansion

Rising complexity and cost of clinical trials is Anticipated to Stimulate Market Growth

Restraint

Regulatory compliance and varying international standards Can Limit the Growth of the Clinical Trials Outsourcing Market

Key Players
  • QuintilesIMS (IQVIA)
  • Covance (LabCorp)
  • Parexel International
  • Charles River Laboratories
  • Medpace
  • ICON plc
  • PRA Health Sciences
  • Syneos Health
  • Wuxi AppTec
  • PPD
  • Eurofins Scientific
  • Clinipace
  • KCR
  • Worldwide Clinical Trials
  • Advanced Clinical
  • Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)
Global Laboratory Temperature Control Units Market is further segmented by region into:
  • North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
  • Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
  • Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
  • Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
  • Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA
Reasons to Purchase this Report
  • Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 3-month post-sales analyst support.
*Please Note: The report will be delivered in 2-3 business days upon order confirmation*

Table of Contents

492 Pages
1 Executive Summary
1.1. Regional Market Share
1.2 Business Trends
1.3. Clinical Trials Outsourcing Market: COVID-19 Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot
2. Research Methodology
2.1 Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4 Primary Research
2.5 Secondary Research
2.5.1 Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation
3. Market Characteristics
3.1 Market Definition
3.2 Clinical Trials Outsourcing Market: COVID-19 Impact
3.3. Key Segmentations
3.4 Key Developments
3.5 Allied Industry Data
4 Clinical Trials Outsourcing Market – Industry Insights
4.1. Industry Segmentation
4.2 COVID-19 overview of world economy
4.3 Industry Ecosystem Channel Analysis
4.4 Innovation & Sustainability
5. Macroeconomic Indicators
6. Recent Developments
7. Market Dynamics
7.1 Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4 Market Restraints
7.5. Market Trends
8 Risk Analysis
9. Market Analysis
9.1 Porter's Five Forces
9.2. PEST Analysis
9.2.1 Political
9.2.2. Economic
9.2.3. Social
9.2.4. Technological
10 Clinical Trials Outsourcing Market
10.1 Overview
10.2. Historical Analysis (2019-2022)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11. Clinical Trials Outsourcing Market Size & Forecast 202 A-203 F
11.1. Overview
11.2 Key Findings
11.3 Market Segmentation
11.3.1. By Phase
11.3.1.1. Phase I
11.3.1.1.1 By Value (USD Million) 2024-203 F
11.3.1.1.2. Market Share (%) 2024-203 F
11.3.1.1.3. Y-o-Y Growth (%) 2024-203 F
11.3.1.2 Phase II
11.3.1.2.1. By Value (USD Million) 2024-203 F
11.3.1.2.2 Market Share (%) 2024-203 F
11.3.1.2.3 Y-o-Y Growth (%) 2024-203 F
11.3.1.3 Phase III
11.3.1.3.1. By Value (USD Million) 2024-203 F
11.3.1.3.2 Market Share (%) 2024-203 F
11.3.1.3.3 Y-o-Y Growth (%) 2024-203 F
11.3.1.4 Phase IV
11.3.1.4.1. By Value (USD Million) 2024-203 F
11.3.1.4.2 Market Share (%) 2024-203 F
11.3.1.4.3 Y-o-Y Growth (%) 2024-203 F
11.3.2. By Application
11.3.2.1 Cancer
11.3.2.1.1. By Value (USD Million) 2024-203 F
11.3.2.1.2 Market Share (%) 2024-203 F
11.3.2.1.3 Y-o-Y Growth (%) 2024-203 F
11.3.2.2. Cardiovascular Diseases
11.3.2.2.1 By Value (USD Million) 2024-203 F
11.3.2.2.2. Market Share (%) 2024-203 F
11.3.2.2.3. Y-o-Y Growth (%) 2024-203 F
11.3.2.3 Nervous System Diseases
11.3.2.3.1 By Value (USD Million) 2024-203 F
11.3.2.3.2. Market Share (%) 2024-203 F
11.3.2.3.3. Y-o-Y Growth (%) 2024-203 F
11.3.2.4. Infectious Diseases
11.3.2.4.1 By Value (USD Million) 2024-203 F
11.3.2.4.2. Market Share (%) 2024-203 F
11.3.2.4.3. Y-o-Y Growth (%) 2024-203 F
11.3.2.5. Musculoskeletal Disease
11.3.2.5.1 By Value (USD Million) 2024-203 F
11.3.2.5.2. Market Share (%) 2024-203 F
11.3.2.5.3. Y-o-Y Growth (%) 2024-203 F
11.3.2.6. Gastroenterology Diseases
11.3.2.6.1 By Value (USD Million) 2024-203 F
11.3.2.6.2. Market Share (%) 2024-203 F
11.3.2.6.3. Y-o-Y Growth (%) 2024-203 F
11.3.2.7. Others
11.3.2.7.1 By Value (USD Million) 2024-203 F
11.3.2.7.2. Market Share (%) 2024-203 F
11.3.2.7.3. Y-o-Y Growth (%) 2024-203 F
11.3.3 By Services Type
11.3.3.1 Protocol Designing
11.3.3.1.1. By Value (USD Million) 2024-203 F
11.3.3.1.2 Market Share (%) 2024-203 F
11.3.3.1.3 Y-o-Y Growth (%) 2024-203 F
11.3.3.2. Site Identification
11.3.3.2.1 By Value (USD Million) 2024-203 F
11.3.3.2.2. Market Share (%) 2024-203 F
11.3.3.2.3. Y-o-Y Growth (%) 2024-203 F
11.3.3.3. Patient Recruitment
11.3.3.3.1 By Value (USD Million) 2024-203 F
11.3.3.3.2. Market Share (%) 2024-203 F
11.3.3.3.3. Y-o-Y Growth (%) 2024-203 F
11.3.3.4. Laboratory Services
11.3.3.4.1 By Value (USD Million) 2024-203 F
11.3.3.4.2. Market Share (%) 2024-203 F
11.3.3.4.3. Y-o-Y Growth (%) 2024-203 F
11.3.3.5. Bioanalytical Testing Services
11.3.3.5.1 By Value (USD Million) 2024-203 F
11.3.3.5.2. Market Share (%) 2024-203 F
11.3.3.5.3. Y-o-Y Growth (%) 2024-203 F
11.3.3.6. Clinical Trial Data Management Services
11.3.3.6.1 By Value (USD Million) 2024-203 F
11.3.3.6.2. Market Share (%) 2024-203 F
11.3.3.6.3. Y-o-Y Growth (%) 2024-203 F
11.3.3.7. Others
11.3.3.7.1 By Value (USD Million) 2024-203 F
11.3.3.7.2. Market Share (%) 2024-203 F
11.3.3.7.3. Y-o-Y Growth (%) 2024-203 F
11.3.4 By End-User
11.3.4.1 Pharmaceutical & Biopharmaceutical Companies
11.3.4.1.1. By Value (USD Million) 2024-203 F
11.3.4.1.2 Market Share (%) 2024-203 F
11.3.4.1.3 Y-o-Y Growth (%) 2024-203 F
11.3.4.2. Medical Device Companies
11.3.4.2.1 By Value (USD Million) 2024-203 F
11.3.4.2.2. Market Share (%) 2024-203 F
11.3.4.2.3. Y-o-Y Growth (%) 2024-203 F
11.3.4.3. Others
11.3.4.3.1 By Value (USD Million) 2024-203 F
11.3.4.3.2. Market Share (%) 2024-203 F
11.3.4.3.3. Y-o-Y Growth (%) 2024-203 F
12 North America Clinical Trials Outsourcing Market Size & Forecast 202 A-203 F
12.1 Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Phase
12.3.2 By Application
12.3.3 By Services Type
12.3.4. By End-User
12.4. Country
12.4.1. United States
12.4.2. Canada
13 Europe Clinical Trials Outsourcing Market Size & Forecast 202 A-203 F
13.1 Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1 By Phase
13.3.2 By Application
13.3.3 By Services Type
13.3.4. By End-User
13.4 Country
13.4.1 Germany
13.4.2. United Kingdom
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14 Asia-Pacific Clinical Trials Outsourcing Market Size & Forecast 202 A-203 F
14.1. Overview
14.2. Key Findings
14.3 Market Segmentation
14.3.1 By Phase
14.3.2. By Application
14.3.3. By Services Type
14.3.4. By End-User
14.4. Country
14.4.1 India
14.4.2. China
14.4.3. South Korea
14.4.4 Japan
14.4.5 Rest of APAC
15 Middle East and Africa Clinical Trials Outsourcing Market Size & Forecast 202 A-203 F
15.1 Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1 By Phase
15.3.2 By Application
15.3.3 By Services Type
15.3.4. By End-User
15.4 Country
15.4.1. Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4 South Africa
15.4.5. Rest of Middle East and Africa
16. Latin America Clinical Trials Outsourcing Market Size & Forecast 202 A-203 F
16.1 Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Phase
16.3.2 By Application
16.3.3 By Services Type
16.3.4. By End-User
16.4 Country
16.4.1. Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America
17. Competitive Landscape
17.1 Company market share, 2023
17.2. Key player overview
17.3. Key stakeholders
18. Company Profiles
18.1. QuintilesIMS (IQVIA)
18.1.1 Company Overview
18.1.2 Financial Overview
18.1.3 Key Product; Analysis
18.1.4 Company Assessment
18.1.4.1 Product Portfolio
18.1.4.2 Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2. Covance (LabCorp)
18.3. Parexel International
18.4. Charles River Laboratories
18.5. Medpace
18.6. ICON plc
18.7. PRA Health Sciences
18.8. Syneos Health
18.9. Wuxi AppTec
18.10. PPD
18.11 Eurofins Scientific
18.12. Clinipace
18.13. KCR
18.14. Worldwide Clinical Trials
18.15. Advanced Clinical
18.16. Other Prominent Players
19. Appendix
20 Consultant Recommendation

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us